N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
申请人:Norwich Eaton Pharmaceuticals, Inc.
公开号:EP0321431A1
公开(公告)日:1989-06-21
The present invention involves certain N-hydroxy-5-phenyl-2-furancarboximidamides, pharmaceutical compositions containing such compounds, and methods for increasing the contractile force of cardiac muscle of a mammal which comprises systemically administering such compounds to a mammal.